-
The University of Tokyo and Chitose Laboratory Drive New Development in Digital Design for Manufacturing Process of Antibody Drugs ―Mathematical model development of cultivation process with full utilization of data from automated experiments―
-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
-
World’s First 100% Bio-PET Resin from Microalgae – On display at the Japan Pavilion during the Expo 2025 Osaka, Kansai
-
“ALGAL by MATSURI” Exhibition Unveiled! Realizing Circular Manufacturing with Algae at the Factory Area of the Japan Pavilion, Expo 2025 Osaka, Kansai
-
“ALGAL by MATSURI”: an Exhibition of Circular Manufacturing Using Algae in Collaboration with 10 Partner Companies at the Factory Area of the Japan Pavilion at Expo 2025 Osaka, Kansai
-
CHITOSE Partners as Technical Supervisor for Algae-Focused “Farm Area” Exhibit at Japan Pavilion for Osaka Expo 2025
-
CHITOSE Group, Successfully Concludes Capital Increase of 21M USD Scale through Third-Party Allotment
-
CHITOSE Group, Successfully Concludes Capital Increase of 7M USD Scale from Shiseido and Forms Strategic Partnership ― Accelerate a Microalgae-based Circular Manufacturing in a Cosmetic Industry —
